Ergomed plc

Ergomed plc is a global clinical research organization (CRO) specializing in clinical trial management, pharmacovigilance, regulatory services, and specialized drug development solutions for pharmaceutical, biotechnology, and healthcare companies. Founded in 1997 and headquartered in Guildford, United Kingdom, Ergomed supports the development of innovative medicines across multiple therapeutic areas worldwide.

The company provides a wide range of clinical research services including Phase I–IV clinical trials, clinical operations, patient recruitment, regulatory affairs, safety monitoring, pharmacovigilance, medical writing, and clinical data management. Ergomed has particular expertise in complex clinical studies, rare diseases, oncology, neurology, and specialty medicines.

Ergomed operates through two major service divisions: clinical research services and pharmacovigilance solutions. Its clinical research teams help sponsors design and manage efficient clinical studies, while its safety experts support ongoing monitoring and regulatory reporting throughout the product lifecycle.

The company uses technology-enabled research approaches and global clinical networks to improve trial efficiency, patient participation, and data quality. Ergomed works with pharmaceutical companies, biotechnology organizations, and emerging healthcare innovators to accelerate the development of new therapies.

Ergomed follows internationally recognized clinical research standards, including Good Clinical Practice (GCP), ICH guidelines, FDA regulations, EMA requirements, and global quality management practices.

With decades of experience in clinical development and safety services, Ergomed has established itself as a trusted partner for organizations seeking specialized clinical research expertise, particularly in complex therapeutic areas where scientific knowledge and operational excellence are essential.